MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-25-2026
Soleno Therapeutics P/S Ratio 2011-2026 | SLNO
Annual P/S Ratio Soleno Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10.9 | - | - | - | - | - | - | - | - | 9.03 | 32.6 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 32.6 | 9.03 | 17.5 |
P/S Ratio of other stocks in the Diagnostics research industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
1.72 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
6.64 | $ 116.17 | 0.54 % | $ 35.3 B |  USA |
|
Akumin
AKU
|
0.1 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
13.5 | - | -61.36 % | $ 2.46 M | USA |
 |
Illumina
ILMN
|
3.75 | $ 128.13 | 0.2 % | $ 20.4 B | USA |
 |
Co-Diagnostics
CODX
|
9.4 | $ 1.67 | - | $ 2.22 M | USA |
 |
Aspira Women's Health
AWH
|
5.55 | - | -6.19 % | $ 10.5 M | USA |
 |
Lantheus Holdings
LNTH
|
3.32 | $ 84.55 | 0.26 % | $ 5.71 B | USA |
 |
Medpace Holdings
MEDP
|
5.12 | $ 416.87 | 1.54 % | $ 12 B | USA |
 |
Biocept
BIOC
|
0.229 | - | -13.05 % | $ 7.29 M | USA |
 |
Castle Biosciences
CSTL
|
2.14 | $ 25.33 | 3.56 % | $ 704 M | USA |
 |
Chembio Diagnostics
CEMI
|
0.254 | - | 0.22 % | $ 16.8 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
1.8 | $ 27.56 | 0.33 % | $ 20 B |  Niderland |
 |
CareDx, Inc
CDNA
|
2.61 | $ 21.59 | 1.7 % | $ 1.15 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
5.71 | - | - | $ 562 M |  Britain |
 |
Senseonics Holdings
SENS
|
9.94 | $ 7.13 | 1.13 % | $ 298 M | USA |
 |
DermTech
DMTK
|
2.77 | - | -11.32 % | $ 2.94 M | USA |
 |
Enzo Biochem
ENZ
|
0.0018 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
6 | - | - | $ 19.8 B | USA |
 |
Fulgent Genetics
FLGT
|
1.65 | $ 16.0 | -1.9 % | $ 484 M | USA |
 |
Thermo Fisher Scientific
TMO
|
4.4 | $ 468.52 | -0.22 % | $ 177 B | USA |
 |
Global Cord Blood Corporation
CO
|
0.196 | - | - | $ 399 M |  China |
 |
Trinity Biotech plc
TRIB
|
1.47 | $ 0.64 | -1.51 % | $ 61.9 M |  Irlanda |
 |
Fluidigm Corporation
FLDM
|
3.48 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
1.36 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
2.9 | - | 0.12 % | $ 80.1 M | China |
 |
Twist Bioscience Corporation
TWST
|
4.15 | $ 60.4 | -0.89 % | $ 3.61 B | USA |
 |
Charles River Laboratories International
CRL
|
1.92 | $ 172.02 | 1.33 % | $ 8.53 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
2.47 | - | - | $ 10.7 B | USA |
 |
Guardant Health
GH
|
13.7 | $ 90.04 | 1.27 % | $ 11.3 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
0.469 | - | -20.0 % | $ 1.06 M | USA |
 |
Heska Corporation
HSKA
|
3.28 | - | - | $ 1.31 B | USA |
 |
Interpace Biosciences
IDXG
|
0.19 | $ 1.91 | -3.29 % | $ 8.45 M | USA |
 |
Motus GI Holdings
MOTS
|
3.1 | - | -34.28 % | $ 263 K |  Israel |
 |
QIAGEN N.V.
QGEN
|
5.03 | - | - | $ 10.6 B | Niderland |
 |
Neogen Corporation
NEOG
|
1.14 | $ 9.51 | -0.37 % | $ 2.06 B | USA |
 |
Biomerica
BMRA
|
1.35 | $ 2.16 | 0.86 % | $ 4.96 M | USA |
 |
National Research Corporation
NRC
|
2.29 | $ 17.09 | -0.81 % | $ 383 M | USA |
 |
ICON Public Limited Company
ICLR
|
3.25 | $ 100.76 | -1.38 % | $ 8.31 B | Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
1.71 | $ 263.91 | 0.06 % | $ 22 B | USA |
 |
OpGen
OPGN
|
1.76 | - | -16.95 % | $ 1.54 M | USA |
 |
NeoGenomics
NEO
|
2.04 | $ 8.6 | 3.68 % | $ 1.1 B | USA |
 |
Myriad Genetics
MYGN
|
0.496 | $ 4.76 | -0.31 % | $ 441 M | USA |
 |
Natera
NTRA
|
6.47 | $ 205.87 | 1.04 % | $ 20.3 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
2.11 | $ 196.59 | 0.19 % | $ 21.8 B | USA |
 |
Invitae Corporation
NVTA
|
4.18 | - | - | $ 21.2 M | USA |
 |
PerkinElmer
PKI
|
5.13 | - | -0.91 % | $ 14.7 B | USA |